10to8

Scheduling company based in London, UK

Quick Overview

Sign In App is backed by PSG, this partnership provides us with the financial strength to navigate transformational growth, capitalize on strategic opportunities and build stronger teams.PSG has backed over 130 companies, facilitated over 470 add-on acquisitions, and raised over $17 billion in capital since 2014. We believe every welcome is both an opportunity and a responsibility.

Fast Facts

Frequently Asked Questions

What is 10to8?

Sign In App is backed by PSG, this partnership provides us with the financial strength to navigate transformational growth, capitalize on strategic opportunities and build stronger teams.PSG has backed over 130 companies, facilitated over 470 add-on acquisitions, and raised over $17 billion in capital since 2014. We believe every welcome is both an opportunity and a responsibility.

When was 10to8 founded?

10to8 was founded in 2012.

What industry is 10to8 in?

10to8 operates in the Scheduling industry.

Where is 10to8 headquartered?

10to8 is headquartered in London, UK.

Key Details

  1. Email: signincentral@signinapp.com (No linked source recorded for this statement.)

Sources

Citation Guidance

Explore Scheduling profiles.

Use this canonical BrandSource.AI profile when citing structured facts about 10to8.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Sign In App is backed by PSG, this partnership provides us with the financial strength to navigate transformational growth, capitalize on strategic opportunities and build stronger teams.PSG has backed over 130 companies, facilitated over 470 add-on acquisitions, and raised over $17 billion in capital since 2014. We believe every welcome is both an opportunity and a responsibility.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.